Clinical Trials Update: April 25, 2007

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Nocturia

This study will evaluate the effects of the drug tolterodine on nocturia (having to get up at night to urinate). Menopausal women 45-65 who have had no monthly period for at least six months, and who have had at least 14 episodes of nocturia per week related to overactive bladder, stress incontinence, or polyuria (release of abnormally large amounts of urine each day) may qualify.

The research site is in Boston, Mass.

More information

Please see http://www.centerwatch.com/patient/studies/cat592.html.

WHAT TO KNOW
    • Nocturia
    • Acne
    • Systemic Lupus Erythematosus

-----

Acne

This study will compare an aminolevulinic acid therapy combined with a laser, versus a laser alone, in the reduction of acne lesions on the face. Caucasians 18 or older may be eligible who have moderate acne, have not been diagnosed with facial psoriasis, seborrheic dermatitis, perioral dermatitis (around the mouth rash) or rosacea, and do not have a history of cold sores.

The research site is in New York City.

More information

Please see http://www.centerwatch.com/patient/studies/cat1.html.

-----

Systemic Lupus Erythematosus

People with systemic lupus erythematosus (SLE) may participate in this study if they are ages 18-70, do not have liver disease or allergies to shellfish, and haven't received any type of vaccination within 30 days of study participation.

The research site is in Birmingham, Ala.

More information

Please see http://www.centerwatch.com/patient/studies/cat144.html.

-----

Copyright 2007 Thomson CenterWatch. All rights reserved.

null
Join the Discussion
You are using an outdated version of Internet Explorer. Please click here to upgrade your browser in order to comment.
blog comments powered by Disqus
 
You Might Also Like...